SCHEMBL7366837

SCHEMBL7366837

CC(=O)Oc1ccc2c(=O)c3c(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c(OC(C)=O)c3sc2c1OC(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.41
ALDH1A1 P00352 5/20 0.41
MAPT P10636 4/20 0.41
RECQL P46063 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
GAA P10253 3/20 0.41
KMT2A Q03164 3/20 0.41
POLB P06746 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
APEX1 P27695 2/20 0.41
BLM P54132 2/20 0.41
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
HTT P42858 2/20 0.40
HPGD P15428 2/20 0.39
MPI P34949 1/20 0.39
MAPK1 P28482 2/20 0.37
MEN1 O00255 2/20 0.34
HSD17B10 Q99714 2/20 0.34
ALOX15 P16050 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7366904 0.85 KDM4E (0.49) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL7360070 0.83 KDM4E (0.44) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL7361090 0.73 KDM4E (0.47) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL7474561 0.73 KDM4E (0.36) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL7365521 0.72 MAPT (0.56) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL19006596 0.72 PIM1 (0.42) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL6193853 0.69 HTT (0.54) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL8489585 0.67 HTT (0.48) KDM4EALDH1A1MAPTRECQLTDP1
SCHEMBL16747885 0.66 KDM4E (0.50) KDM4EALDH1A1MAPTTDP1GAA
SCHEMBL28794942 0.65 ABCB11 (0.47) KDM4EALDH1A1MAPTRECQLTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0888052-A4 XANTHONE ANALOGS FOR THE TREATMENT OF INFECTIOUS DISEASES INTERLAB CORP (US) 2002-05-22 EP disclosed
EP-0888052-A1 XANTHONE ANALOGS FOR THE TREATMENT OF INFECTIOUS DISEASES INTERLAB CORPORATION (US) 1999-01-07 EP disclosed
WO-1997034482-A1 XANTHONE ANALOGS FOR THE TREATMENT OF INFECTIOUS DISEASES INTERLAB CORP. (US) 1997-09-25 WO disclosed